Type 2 diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Age: 18-65 years old Type 2 diabetes (fasting blood sugar above 126 mg / dL) Hypertriglyceridemia (triglyceride above 150 mg / dL) has been diagnosed.
Exclusion criteria
Exclusion criteria: Pregnancy and lactation People with type 1 diabetes and tasteless diabetes Insulin injection Smoking Heart, lung, kidney, malignant cancer, immune system disorders, addiction or mental illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipids. Timepoint: Blood samples are taken at the beginning and end of the study. Method of measurement: Blood samples.;Blood glucose. Timepoint: Blood samples are taken at the beginning and end of the study. Method of measurement: Blood samples. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cholesterol. Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;High-density lipoprotein (HDL). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;Low density lipoprotein (LDL). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;Inflammatory factor (hs-CRP). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences